Rhinosinusitis News and Research

RSS
Rhinosinusitis is an inflammation of the paranasal sinuses and the nasal cavity lasting no longer than 4 weeks. It can range from acute viral rhinitis (the common cold) to acute bacterial rhinosinusitis. Fewer than 5 in 1,000 colds are followed by bacterial rhinosinusitis.
Study reports significant under-use of topical INS therapy for chronic rhinosinusitis patients

Study reports significant under-use of topical INS therapy for chronic rhinosinusitis patients

High exposure to unconventional natural gas wells linked to migraine headaches, sinus and fatigue

High exposure to unconventional natural gas wells linked to migraine headaches, sinus and fatigue

Simple blood test can help track rising levels of eosinophils linked to regrowth of sinus polyps

Simple blood test can help track rising levels of eosinophils linked to regrowth of sinus polyps

New NIH grants support research that combines DNA sequence information and electronic medical records

New NIH grants support research that combines DNA sequence information and electronic medical records

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Diabetes linked to increased head and neck cancer risk

Diabetes linked to increased head and neck cancer risk

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

Taste receptors act as first line sentinels against infection in upper airway

Taste receptors act as first line sentinels against infection in upper airway

S. pneumoniae predicts acute sinusitis microbial response

S. pneumoniae predicts acute sinusitis microbial response

Acclarent announces availability of Relieva Spin Balloon Sinuplasty System for sinusitis treatment

Acclarent announces availability of Relieva Spin Balloon Sinuplasty System for sinusitis treatment

Study supports mounting evidence that inflammation may be the cause of chronic rhinosinusitis

Study supports mounting evidence that inflammation may be the cause of chronic rhinosinusitis

‘Limit diagnostic investigations’ in children with recurrent CAP

‘Limit diagnostic investigations’ in children with recurrent CAP

Study identifies national variations in using antibiotics to treat ARS

Study identifies national variations in using antibiotics to treat ARS

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Dectin-1 potential target for nasal polyposis

Dectin-1 potential target for nasal polyposis

Rhinosinusitis without nasal polyps ‘predisposes to psoriasis’

Rhinosinusitis without nasal polyps ‘predisposes to psoriasis’

Taste receptor governs respiratory infection susceptibility

Taste receptor governs respiratory infection susceptibility

Receptor expression sheds light on nasal polyposis

Receptor expression sheds light on nasal polyposis

Loss of normal microbial diversity may be culprit behind chronic sinusitis

Loss of normal microbial diversity may be culprit behind chronic sinusitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.